Position in INVA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$71,306,784
+$15,398,353 QoQ
Shares Held
3,060,377
+9.4% QoQ
Ownership
4.15%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 13.23787886263686.ToString("F0")%
Shared 0.022448214713416025.ToString("F0")%
None 86.73967292264973.ToString("F0")%
Common Shares in INVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026STATE STREET CORP holds $30,288,856,014 across 423 Biotechnology names. INVA ranks #83 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,730,139 | $5,237,976,269 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,664,478 | $3,603,962,281 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,322,698 | $1,099,381,087 | |
| 4 | INSM |
INSMED Inc
|
5,551,699 | $907,813,820 | |
| 5 | INCY |
Incyte Corp
|
9,641,384 | $907,447,062 | |
| 6 | MRNA |
Moderna, Inc.
|
14,861,409 | $754,959,577 | |
| 7 | RPRX |
Royalty Pharma plc
|
10,989,851 | $527,183,152 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
16,186,613 | $448,369,180 |
All Filings in INVA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $71,306,784 | 3,060,377 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $55,908,431 | 2,796,820 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $46,664,739 | 2,556,972 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $49,370,411 | 2,457,462 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $42,855,168 | 2,363,771 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $42,657,924 | 2,458,670 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $47,321,742 | 2,450,634 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $40,483,301 | 2,468,494 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $38,191,333 | 2,505,993 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $40,401,199 | 2,518,778 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $30,764,385 | 2,368,313 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $30,319,766 | 2,381,757 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $26,817,795 | 2,383,804 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $29,865,341 | 2,253,988 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $28,687,079 | 2,470,894 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $36,266,914 | 2,457,108 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $38,923,724 | 2,011,562 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $38,072,613 | 2,207,108 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $37,158,461 | 2,223,726 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $32,474,956 | 2,421,697 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $27,863,611 | 2,331,683 | Shares | Defined | 2021-07-09 | |
| 2020-12-31 | $27,104,896 | 2,187,643 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $22,453,152 | 2,148,627 | Shares | Defined | 2020-11-10 | |
| 2020-06-30 | $31,964,808 | 2,286,467 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $25,913,559 | 2,203,534 | Shares | Defined | 2020-06-19 | |
| No filing history on record for this holder in this stock. | ||||||